{"id":1827,"date":"2025-10-22T10:39:45","date_gmt":"2025-10-22T08:39:45","guid":{"rendered":"https:\/\/okuvision.de\/studies-and-research\/"},"modified":"2026-05-21T13:47:52","modified_gmt":"2026-05-21T11:47:52","slug":"retinitis-pigmentosa-research-evidence","status":"publish","type":"page","link":"https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/","title":{"rendered":"Clinical Trials &amp; Research"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;0&#8243; bottom_padding=&#8221;0&#8243; back_color=&#8221;color-206913&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;126459&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column width=&#8221;1\/1&#8243;]\n<div id=\"cvc-hero_image-6a4d66d02ad0a\" class=\"cvc-element cvc-hero-image cvc-hero-image--violet cvc-hero-image--headline-hl-xl cvc-hero-image--text-large cvc-pattern-top-right-pattern cvc-pattern-bottom-left-pattern\" role=\"region\" aria-label=\"Research and Clinical Trials on Retinitis Pigmentosa (RP)\">\n    \n    <!-- Background Patterns -->\n            <div class=\"cvc-hero-image__pattern cvc-hero-image__pattern--left\" aria-hidden=\"true\"><\/div>\n                <div class=\"cvc-hero-image__pattern cvc-hero-image__pattern--right\" aria-hidden=\"true\"><\/div>\n        \n    <!-- Content Container (max-width, centered) -->\n    <div class=\"cvc-hero-image__container\">\n        \n        <div class=\"cvc-hero-image__inner\">\n            <div class=\"cvc-hero-image__content\">\n                \n                                \n                                                        <h1 class=\"cvc-hero-image__headline font-714446 fontsize-431854\">\n                        Research and Clinical Trials on Retinitis Pigmentosa (RP)                    <\/h1>\n                                \n                <div class=\"cvc-hero-image__text-wrapper\">\n                                            <div class=\"cvc-hero-image__text-content text-lead\">\n                            <p>This page brings together current research on retinitis pigmentosa \u2014 from genetics and disease progression parameters to clinical data on TES with OkuStim\u00ae.<\/p>\n                        <\/div>\n                                        \n                                    <\/div>\n                \n                                \n            <\/div>\n            \n            <!-- Image (breaks out to right edge) -->\n                            <div class=\"cvc-hero-image__image\">\n                    <img width=\"2008\" height=\"1339\" src=\"https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV_Studien-und-Forschung.webp\" class=\"attachment-full size-full\" alt=\"Studien und Forschung\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV_Studien-und-Forschung.webp 2008w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV_Studien-und-Forschung-300x200.webp 300w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV_Studien-und-Forschung-1024x683.webp 1024w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV_Studien-und-Forschung-768x512.webp 768w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV_Studien-und-Forschung-1536x1024.webp 1536w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV_Studien-und-Forschung-350x233.webp 350w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV_Studien-und-Forschung-uai-720x480.webp 720w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV_Studien-und-Forschung-uai-1032x688.webp 1032w\" sizes=\"auto, (max-width: 2008px) 100vw, 2008px\" \/>                <\/div>\n                    <\/div>\n        \n    <\/div>\n    \n<\/div>\n\n\n[\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;220104&#8243;][vc_column width=&#8221;1\/1&#8243;]\n<div id=\"cvc-anchor-nav-6a4d66d02b293\" class=\"cvc-element cvc-anchor-navigation cvc-anchor-navigation--violet\">\n    <div class=\"cvc-anchor-navigation__container\">\n        <nav class=\"cvc-anchor-navigation__nav\" \n             role=\"navigation\" \n             aria-label=\"Anchor navigation\">\n            \n            <ul class=\"cvc-anchor-navigation__list\">\n                                                        <li class=\"cvc-anchor-navigation__item\">\n                        <a href=\"#relevanz-forschung\" \n                           id=\"cvc-anchor-nav-6a4d66d02b293-link-1\"\n                           class=\"cvc-anchor-navigation__link cvc-anchor-navigation__link--active\"\n                           data-smooth-scroll\n                           aria-current=\"location\">\n                            <span class=\"cvc-anchor-navigation__label\">Research Relevance<\/span>\n                                                            <span class=\"cvc-sr-only\">(current section)<\/span>\n                                                    <\/a>\n                    <\/li>\n                                                        <li class=\"cvc-anchor-navigation__item\">\n                        <a href=\"#genetik-vererbung\" \n                           id=\"cvc-anchor-nav-6a4d66d02b293-link-2\"\n                           class=\"cvc-anchor-navigation__link\"\n                           data-smooth-scroll\n                           >\n                            <span class=\"cvc-anchor-navigation__label\">Genetics and Inheritance<\/span>\n                                                    <\/a>\n                    <\/li>\n                                                        <li class=\"cvc-anchor-navigation__item\">\n                        <a href=\"#therapieansaetze\" \n                           id=\"cvc-anchor-nav-6a4d66d02b293-link-3\"\n                           class=\"cvc-anchor-navigation__link\"\n                           data-smooth-scroll\n                           >\n                            <span class=\"cvc-anchor-navigation__label\">Therapeutic Approaches<\/span>\n                                                    <\/a>\n                    <\/li>\n                                                        <li class=\"cvc-anchor-navigation__item\">\n                        <a href=\"#studien\" \n                           id=\"cvc-anchor-nav-6a4d66d02b293-link-4\"\n                           class=\"cvc-anchor-navigation__link\"\n                           data-smooth-scroll\n                           >\n                            <span class=\"cvc-anchor-navigation__label\">Clinical Trials TES<\/span>\n                                                    <\/a>\n                    <\/li>\n                            <\/ul>\n        <\/nav>\n    <\/div>\n<\/div>\n[\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;206058&#8243; row_name=&#8221;Relevanz Forschung&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;742058&#8243;]Why research<br \/>\nis essential[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;542260&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;163215&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text uncode_shortcode_id=&#8221;122633&#8243;]Retinitis pigmentosa (RP) is a hereditary retinal disease that can lead to vision loss over years. Research helps to understand disease mechanisms, measure progression, and evaluate treatment options\u2014with tangible benefits for patients, families, and the healthcare system. Reviews describe not only the medical but also the economic and psychosocial impacts of RP. Typical for RP: night blindness in early stages, later constriction of the visual field leading to &#8220;tunnel vision&#8221;\u2014this clinical development is well documented and helps to select meaningful study endpoints. Conclusion: Research is the foundation for realistic expectations and better care decisions.<sup>1<\/sup>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;944703&#8243; row_name=&#8221;genetik-vererbung&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;137717&#8243;]Genetics &amp; Inheritance\u2014Fundamentals[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;542260&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;163215&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text uncode_shortcode_id=&#8221;366320&#8243;]RP has pronounced genetic diversity: reviews describe mutation-caused forms in \u226580 genes; inheritance is predominantly autosomal recessive (~20%), autosomal dominant (10\u201320%), or X-linked (~10%), with sporadic cases also occurring. Genetic diagnosis provides important information for counseling, study eligibility, and \u2014for suitable subtypes\u2014 targeted therapies.<sup>2<\/sup>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;0&#8243; bottom_padding=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;187729&#8243; row_name=&#8221;therapieansaetze&#8221;][vc_column width=&#8221;1\/1&#8243;]\n<div id=\"cvc-cta-6a4d66d02b399\" class=\"cvc-element cvc-cta cvc-cta--headline-hl-xl cvc-cta--text-regular cvc-cta--without-image\" role=\"region\" aria-label=\"Therapeutic Approaches\nin Research\">\n    \n    <!-- Image Area with Pattern (only for \"Mit Bild\" variant with actual image) -->\n        \n    <!-- Dark Background Content Area (SINGLE BLOCK for both variants) -->\n    <div class=\"cvc-cta__dark-wrapper style-color-jevc-bg\">\n        \n        <!-- Pattern Top Right - nur f\u00fcr \"Ohne Bild\" Variante -->\n                    <div class=\"cvc-cta__pattern cvc-cta__pattern--top-right\" aria-hidden=\"true\"><\/div>\n                \n        <!-- Pattern Bottom Left - f\u00fcr beide Varianten -->\n        <div class=\"cvc-cta__pattern cvc-cta__pattern--bottom-left\" aria-hidden=\"true\"><\/div>\n        \n        <!-- Content Container (max-width 1200px, centered) -->\n        <div class=\"cvc-cta__container\">\n            <div class=\"cvc-cta__content style-dark\">\n                \n                                    <h2 class=\"cvc-cta__headline text-color-233806-color font-714446 fontsize-431854\">\n                        Therapeutic Approaches<br \/><br \/>\nin Research                    <\/h2>\n                                \n                <div class=\"cvc-cta__text-wrapper\">\n                                            <div class=\"cvc-cta__text uncode_text_column\">\n                            <p>International literature describes several approaches:<\/p>\n<ul>\n<li>Gene therapy: For RPE65-associated hereditary retinal dystrophies, an approved gene therapy exists (voretigene neparvovec); guidelines and assessment documents confirm clinical benefit with appropriate patient selection.<sup>1<\/sup><\/li>\n<li>Cell-based approaches: The goal is to regenerate or stabilize damaged retinal areas in the future (currently predominantly in studies).<sup>1<\/sup><\/li>\n<li>Optogenetics &amp; retinal implants: Concepts for reactivating remaining retinal circuits and supplementing function in advanced stages\u2014also primarily in the study context.<sup>1<\/sup><\/li>\n<\/ul>\n<p>Why do studies often measure the visual field? In RP, peripheral vision is particularly affected. The area of the retina with intact photoreceptors (VFA, visual field area) decreases exponentially over time. Studies report annual decline rates (ADR) of approximately 5\u201317%, depending on the measurement method.<sup>2<\/sup><\/p>\n                        <\/div>\n                                        \n                                            <div class=\"cvc-cta__buttons\" role=\"group\" aria-label=\"Aktionen\">\n                                                        \n                                                            <a href=\"\/en\/retinitis-pigmentosa-treatment\/\" \n                                   class=\"oku-button oku-button-md oku-button-white cvc-cta__button cvc-cta__button--secondary\"\n                                                                                                         aria-label=\"More on TES Study Status and Therapy\">\n                                    <span>More on TES Study Status and Therapy<\/span>\n                                    <i class=\"fa fa-arrow-right2\" aria-hidden=\"true\"><\/i>\n                                <\/a>\n                                                    <\/div>\n                                    <\/div>\n                \n            <\/div>\n        <\/div>\n        \n    <\/div>\n    \n<\/div>\n[\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;892533&#8243; row_name=&#8221;studien&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;101376&#8243;]Clinical Trials on TES Therapy with OkuStim\u00ae[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;542260&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;163215&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text uncode_shortcode_id=&#8221;758616&#8243;]Transcorneal electrical stimulation (TES) is a noninvasive stimulation of the ocular surface with weak alternating currents. The goal is to activate cellular protective mechanisms of the retina and thereby preserve function longer. In an interventional randomized 12-month study (weekly application, one eye treated), visual field area loss was lower in treated eyes\u2014 and the effect showed dose dependence (higher current intensity, greater benefit).<sup>2<\/sup>  <\/p>\n<p><b>Safety:<\/b> In the published analysis, adverse events were predominantly mild and transient, most commonly dry eyes, which improved rapidly with tear substitutes; a current-intensity-dependent increase in serious adverse events was not observed.<sup>2<\/sup><\/p>\n<p><b>Important:<\/b> TES does not cure RP. However, studies have shown that TES can slow visual field loss. Whether TES is suitable for you should be discussed with your treating physician.<sup>2<\/sup>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; cvc_maxwidth=&#8221;1920&#8243; uncode_shortcode_id=&#8221;490954&#8243;][vc_column column_width_percent=&#8221;70&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; override_padding=&#8221;yes&#8221; column_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;126108&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;188569&#8243;]What does this mean for patients?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;142718&#8243;]<\/p>\n<ul>\n<li>Set realistic expectations: RP progression is heterogeneous. The visual field decreases on average by approximately 5\u201317% annually\u2014individual courses may vary. Comparable measurements (same method\/setting) are crucial.<sup>2<\/sup>  <\/li>\n<li>Check genetics: A genetic test can open therapy and study pathways and helps with family counseling.<sup>1<\/sup><\/li>\n<li>Actively strengthen quality of life: Research shows significant daily life and participation burdens (mobility, work, mental health). Rehabilitation, assistive devices, and counseling are therefore advisable early on.<sup>1<\/sup> <\/li>\n<li>Know specific options: For RPE65 mutations, gene therapy may be an option; for many other forms, clinical studies are important.<sup>1<\/sup><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;609480&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_separator uncode_shortcode_id=&#8221;100849&#8243; sep_color_type=&#8221;uncode-solid&#8221; sep_color_solid=&#8221;#cddfed&#8221;][vc_custom_heading heading_semantic=&#8221;h6&#8243; text_size=&#8221;h4&#8243; uncode_shortcode_id=&#8221;493566&#8243;]References[\/vc_custom_heading][vc_column_text text_lead=&#8221;small&#8221; uncode_shortcode_id=&#8221;203763&#8243;]1 Cross N et al. Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs. Clin Ophthalmol. 2022;16:1993\u20132010.   <\/p>\n<p>2 Stett A et al. TcES dose-dependently slows visual field loss in RP. TVST. 2023;12(2):29.    (Natural-history context: ADR ~5\u201317%.)[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-206913&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;118356&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;4&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;152446&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;109998&#8243;]Insights into Therapy,<br \/>\nResearch &amp; Company[\/vc_custom_heading][vc_row_inner][vc_column_inner width=&#8221;1\/1&#8243;][uncode_index el_id=&#8221;index-974899&#8243; index_type=&#8221;carousel&#8221; loop=&#8221;size:3|order_by:date|post_type:post|categories:88|taxonomy_count:10&#8243; carousel_lg=&#8221;3&#8243; carousel_md=&#8221;2&#8243; carousel_sm=&#8221;1&#8243; thumb_size=&#8221;sixteen-nine&#8221; gutter_size=&#8221;3&#8243; post_items=&#8221;media|featured|onpost|original,date,title|-,text|excerpt|200,category|colorbg|relative|display-icon&#8221; carousel_height=&#8221;equal&#8221; carousel_interval=&#8221;3000&#8243; carousel_navspeed=&#8221;400&#8243; advanced_nav=&#8221;yes&#8221; el_id1=&#8221;index-974899&#8243; stage_padding=&#8221;0&#8243; single_back_color=&#8221;color-942029&#8243; single_overlay_opacity=&#8221;50&#8243; single_padding=&#8221;2&#8243; single_title_dimension=&#8221;h4&#8243; single_border=&#8221;yes&#8221; uncode_shortcode_id=&#8221;175973&#8243;][uncode_carousel_nav padding=&#8221;0&#8243; h_align=&#8221;center&#8221; hide_arrows=&#8221;yes&#8221; dots_style=&#8221;lines&#8221; hide_counter=&#8221;yes&#8221; uncode_shortcode_id=&#8221;207978&#8243; target=&#8221;index-974899&#8243; dot_single_width=&#8221;12&#8243; dot_single_active=&#8221;24&#8243; dot_single_height=&#8221;12&#8243; dot_single_radius=&#8221;999&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;0&#8243; bottom_padding=&#8221;0&#8243; back_color=&#8221;color-206913&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;126459&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column width=&#8221;1\/1&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1827","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Retinitis Pigmentosa: Studies &amp; Research Overview<\/title>\n<meta name=\"description\" content=\"Current research on RP: genetics, progression, quality of life. Clinical data on TES (OkuStim\u00ae) and perspectives for patients\u2014explained clearly.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Trials &amp; Research\" \/>\n<meta property=\"og:description\" content=\"Current research on RP: genetics, progression, quality of life. Clinical data on TES (OkuStim\u00ae) and perspectives for patients\u2014explained clearly.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/\" \/>\n<meta property=\"og:site_name\" content=\"Okuvision\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-21T11:47:52+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/retinitis-pigmentosa-research-evidence\\\/\",\"url\":\"https:\\\/\\\/okuvision.de\\\/en\\\/retinitis-pigmentosa-research-evidence\\\/\",\"name\":\"Retinitis Pigmentosa: Studies & Research Overview\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#website\"},\"datePublished\":\"2025-10-22T08:39:45+00:00\",\"dateModified\":\"2026-05-21T11:47:52+00:00\",\"description\":\"Current research on RP: genetics, progression, quality of life. Clinical data on TES (OkuStim\u00ae) and perspectives for patients\u2014explained clearly.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/retinitis-pigmentosa-research-evidence\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/okuvision.de\\\/en\\\/retinitis-pigmentosa-research-evidence\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/retinitis-pigmentosa-research-evidence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Trials &amp; Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\",\"name\":\"Okuvision\",\"description\":\"\u2013 Sehen erhalten\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/okuvision.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Retinitis Pigmentosa: Studies & Research Overview","description":"Current research on RP: genetics, progression, quality of life. Clinical data on TES (OkuStim\u00ae) and perspectives for patients\u2014explained clearly.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Trials &amp; Research","og_description":"Current research on RP: genetics, progression, quality of life. Clinical data on TES (OkuStim\u00ae) and perspectives for patients\u2014explained clearly.","og_url":"https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/","og_site_name":"Okuvision","article_modified_time":"2026-05-21T11:47:52+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/","url":"https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/","name":"Retinitis Pigmentosa: Studies & Research Overview","isPartOf":{"@id":"https:\/\/okuvision.de\/en\/#website"},"datePublished":"2025-10-22T08:39:45+00:00","dateModified":"2026-05-21T11:47:52+00:00","description":"Current research on RP: genetics, progression, quality of life. Clinical data on TES (OkuStim\u00ae) and perspectives for patients\u2014explained clearly.","breadcrumb":{"@id":"https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/okuvision.de\/en\/retinitis-pigmentosa-research-evidence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/okuvision.de\/en\/"},{"@type":"ListItem","position":2,"name":"Clinical Trials &amp; Research"}]},{"@type":"WebSite","@id":"https:\/\/okuvision.de\/en\/#website","url":"https:\/\/okuvision.de\/en\/","name":"Okuvision","description":"\u2013 Sehen erhalten","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/okuvision.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages\/1827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/comments?post=1827"}],"version-history":[{"count":13,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages\/1827\/revisions"}],"predecessor-version":[{"id":2361,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages\/1827\/revisions\/2361"}],"wp:attachment":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/media?parent=1827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}